Related Experiment Videos
Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?
Andrea-Romana Prusa1, Erika Marton, Margit Rosner
1Obstetrics and Gynecology, University of Vienna, Prenatal Diagnosis and Therapy, Währinger Gürtel 18-20, 1090 Vienna, Austria.
Human Reproduction (Oxford, England)
|July 2, 2003
Summary
Human amniotic fluid contains a distinct population of Oct-4-positive stem cells. These cells are actively dividing and offer a potential new source for stem cell therapies without ethical concerns.
Area of Science:
- Stem cell biology
- Regenerative medicine
Background:
- Pluripotent stem cells hold therapeutic potential for various diseases.
- Oct-4 is a key marker for pluripotent stem cells found in embryonic tissues.
- Identifying novel, ethically sourced stem cell populations is crucial.
Purpose of the Study:
- To investigate human amniotic fluid as a potential source of pluripotent stem cells.
- To characterize Oct-4 expressing cells within human amniotic fluid.
Main Methods:
- RT-PCR analysis of Oct-4, stem cell factor, vimentin, and alkaline phosphatase mRNA.
- Western blot and immunocytochemistry for Oct-4 protein detection.
- Double immunostaining for cyclin A to assess cell proliferation.
Main Results:
- Human amniotic fluid contains a distinct population of Oct-4-positive cells localized in the nucleus.
- These Oct-4-positive cells express stem cell factor, vimentin, and alkaline phosphatase mRNA.
- Oct-4-positive amniotic fluid cells demonstrate active division, indicated by cyclin A expression.
Conclusions:
- Human amniotic fluid is a promising new source for isolating Oct-4-positive stem cells.
- This discovery bypasses ethical considerations linked to embryonic stem cell research.
- Potential for developing new therapeutic strategies using amniotic fluid-derived stem cells.